Test for C- Reactive Protein
- UID
- IMP/MD/2018/000203_374d9d3528bfebe06ef9774ccf9c947e_e64e96809cc55646a3dca57b5e68b0aa
- Device class
- Class C
- Brand name
- QDx Instacheck™ AFP
- License holder
- DiaSys Diagnostics India Private Limited
- Approving authority
- CDSCO
- Product information
- QDx Instacheck™ hsCRP - All in one along with QDx Instacheck™ Reader is a fluorescence immunoassay for quantitative determination of C-reactive protein (QDx Instacheck™ AFP) in human serum, plasma, or whole blood. The test is used as an aid to predict future cardiovascular diseases (QDx Instacheck™ AFP) as well as to see infection inflammation
Test for C- Reactive Protein is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_374d9d3528bfebe06ef9774ccf9c947e_e64e96809cc55646a3dca57b5e68b0aa. This device is marketed under the brand name QDx Instacheck™ AFP. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.